Chemical genetics-based development of small molecules targeting hepatitis C virus

Area of Science:

• Virology and Medicinal Chemistry
• Chemical Biology and Drug Discovery

Background:

• Hepatitis C virus (HCV) infection remains a major global health concern with limited therapeutic options.
• Current treatments involve direct-acting antivirals (DAAs), evolving from early peg-IFNα/RBV regimens to newer, more effective agents.
• Developing novel HCV therapies requires innovative strategies for target identification and drug development.

Purpose of the Study:

• To review small molecules in Hepatitis C virus (HCV) drug discovery.
• To highlight the application of chemical genetics in identifying targets for HCV therapy.
• To present successful examples of targets identified using chemical genetic methods.

Main Methods:

• Utilizing chemical genetics to study the HCV lifecycle and screen for antiviral agents.
• Employing forward and reverse chemical genetics screening approaches.
• Investigating small molecules targeting specific HCV proteins and their mechanism of action (MOA).

Main Results:

• Chemical genetics provides a powerful strategy for identifying novel drug targets in HCV.
• This approach has led to the discovery of various small molecules with potential antiviral activity.
• Successful examples of target identification using chemical genetics are presented.

Conclusions:

• Chemical genetics is a valuable tool for advancing HCV drug discovery.
• The insights gained can accelerate the development of new and improved therapies for Hepatitis C.
• Continued application of these methods is crucial for combating HCV infection.